StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Wednesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Shares of NYSE:BTX opened at $2.06 on Wednesday. The company has a 50 day moving average price of $2.20 and […]